Updated Jul 16, 2026
Accardi Mario Alberto has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $442K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-24 | CNTA | Centessa Pharmaceuticals plc | D — Derivative transaction | 243.3K | — | |
| 2026-05-19 | CNTA | Centessa Pharmaceuticals plc | F — Tax withholding / forfeiture | 604 | $39.42 | $24K |
| 2026-02-03 | CNTA | Centessa Pharmaceuticals plc | A — Grant or award | 68.0K | $0.00 | |
| 2026-02-03 | CNTA | Centessa Pharmaceuticals plc | F — Tax withholding / forfeiture | 2.9K | $24.57 | $72K |
| 2025-09-16 | CNTA | Centessa Pharmaceuticals plc | S — Open-market sale | 742 | $22.02 | $16K |
| 2025-09-16 | CNTA | Centessa Pharmaceuticals plc | S — Open-market sale | 7.4K | $21.33 | $159K |
| 2025-09-09 | CNTA | Centessa Pharmaceuticals plc | S — Open-market sale | 7.0K | $20.00 | $140K |
| 2025-09-09 | CNTA | Centessa Pharmaceuticals plc | M — Option exercise | 5.0K | $8.01 | $40K |
| 2025-08-01 | CNTA | Centessa Pharmaceuticals plc | F — Tax withholding / forfeiture | 597 | $17.17 | $10K |
| 2025-07-29 | CNTA | Centessa Pharmaceuticals plc | S — Open-market sale | 8.3K | $15.23 | $127K |
Accardi Mario Alberto is a corporate insider — currently tracked as Chief Executive Officer, Director of Centessa Pharmaceuticals plc (CNTA). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($442K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Accardi Mario Alberto profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.